| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2373410C A2a receptor agonists |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089311A1 Vanilloid receptor ligands and their use in treatments |
| 08/24/2006 | WO2006089286A2 Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor compounds useful for the treatment and prevention of pain and screening methods therefor |
| 08/24/2006 | WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088840A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088833A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006087355A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | WO2006087147A2 Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia |
| 08/24/2006 | WO2006063178A3 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 08/24/2006 | WO2006063048A3 Ibudilast for treating neuropathic pain and associated syndromes |
| 08/24/2006 | WO2006041843A3 Pharmaceutical dosage form comprising meloxicam |
| 08/24/2006 | WO2006039545A3 Use of parp-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis |
| 08/24/2006 | WO2006025991A3 Isoindoline compounds and methods of making and using the same |
| 08/24/2006 | WO2006018814A3 Oral liquid suspensions of metaxalone |
| 08/24/2006 | WO2006013388A3 Materials and methods for modulating signalling by alpha-v integrin molecules |
| 08/24/2006 | WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/24/2006 | US20060191024 Method for preparing anti-MIF antibodies |
| 08/24/2006 | US20060189684 3-Phenylfuran-2-one derivatives as cox-2 inhibitor |
| 08/24/2006 | US20060189671 Compounds, compositions, and methods |
| 08/24/2006 | US20060189667 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 08/24/2006 | US20060189664 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189621 Benzofuran derivative |
| 08/24/2006 | US20060189613 Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4) |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189567 Compound having affinity with calcified tissue |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/24/2006 | US20060188557 Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor |
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188501 Diagnostic and therapeutic agents for rheumatoid arthritis |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | DE102005007304A1 Triazolderivate Triazole derivatives |
| 08/24/2006 | DE10150824B4 Konzentrat, seine Herstellung und Verwendung Concentrate, its preparation and use |
| 08/24/2006 | CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598459A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | CA2598409A1 Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation |
| 08/24/2006 | CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | CA2594820A1 Macrolides with anti-inflammatory activity |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |
| 08/23/2006 | EP1693382A2 Melanocortin 1 receptor selective compounds |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1693070A1 Procaspase 1 activation inhibitor |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693059A1 Use of rocaglamide derivatives as NF-AT-specific inhibitors for the treatment of certain inflammatory diseases |
| 08/23/2006 | EP1693052A1 Compositions for delivery of drug combinations |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692116A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 08/23/2006 | EP1691814A2 Anti-inflammatory agents |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
| 08/23/2006 | EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1171452B1 Pyrrolidincarbolylamino cyclic disulfides as vcam-vla4 antagonists |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP1126837B1 Fulvic acid and its use in the treatment of various conditions |
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1823072A Inhibitors of P38 and methods of using the same |
| 08/23/2006 | CN1820772A Medicine for treating rheumatic arthritis and its preparing method |
| 08/23/2006 | CN1820752A Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method |
| 08/23/2006 | CN1820747A Injectable long-acting analgesic composition comprising an ester derivative of ketorolac |
| 08/23/2006 | CN1820738A Tramadol hydrochloride slow release dripping pill and its preparing method |
| 08/23/2006 | CN1271067C Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNF & alpha levels |
| 08/23/2006 | CN1270755C Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis |
| 08/23/2006 | CN1270746C Medicine for diminishing the inflammation and reducing the pain, subsiding swelling to dissipate indurated mass, dredging meridian to removing stagnation |
| 08/23/2006 | CN1270740C Ready prepared Chinese medicine for treating angeitis and preparation process |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094903 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/22/2006 | US7094899 Vitreous form of known bradykinin antagonist |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094872 Activated polyethylene glycol esters |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094773 LTA4 hydrolase inhibitors |
| 08/22/2006 | US7094575 For prophylaxis and therapy of phospholipase A2 (PLA2) related inflammatory conditions |
| 08/22/2006 | US7094421 Plaster containing 4-biphenylacetic acid |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/17/2006 | WO2006086500A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |